Ghana Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Ghana Pharmaceuticals and Healthcare Report

Ghana Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Ghana Pharmaceuticals and Healthcare Report
Published Aug 27, 2016
85 pages — Published Aug 27, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

Ghana s evolving demographic and epidemiological profile will provide increased revenue earning opportunities for pharmaceutical companies, particularly those producing non-communicable disease treatments Local drugmakers are in a favourable position for entering joint ventures with foreign pharmaceutical firms, particularly as regional exports are becoming more important. The Ghanaian government is actively making progress towards fulfilling its ambition of being the Economic Communities of West African States (ECOWAS) hub for pharmaceutical and healthcare investment. The government, in association with foreign aid agencies, is upgrading local capacity. Continental drugmakers familiar with the disease burden and local demand will find licence deals with Ghana s local manufacturers, which require investment in order to diversify portfolio and increase output. Improved healthcare facilities funded by international aid agencies and banks, such as plans for a ----bed teaching hospital funded by the Israeli government. ...Removal of tax on some imported raw pharmaceutical materials will make local manufacturers more competitive. Domestic drugmakers gaining support towards achieving WHO qualification and GMP certification.

...Low affordability levels limit large-scale pharmaceutical spending Financial sustainability will continue limit the success of over Ghana s NHIS. The country s regulatory environment is still in need of supply chain tightening and better policy enforcement. Sporadic price mark-ups on medicines cause regional disparities on the same medicines, hindering access. Cheaper generic imports from abroad need to be carefully controlled to prevent competition from wiping out local drug manufacturing, which also lacks investment finance. The implementation of the Common External Tariff (CET) will threaten Ghana s domestic drug manufacturers, as it favours imports of medicines from cheap manufacturing bases in India and China. ...Cheaper generic imports from abroad need to be carefully controlled to prevent competition from wiping out local drug manufacturing, which also lacks investment finance. The implementation of the Common External Tariff (CET) will threaten Ghana s domestic drug manufacturers, as it favours imports of medicines from cheap manufacturing bases in India and China.

...Ghana has a sizeable population to support large-scale drug manufacturing. Ghana s private healthcare sector attracts medical tourists from Nigeria, boosting sales, especially as medical staff retention and training is generally considered better than in its West African peers. ...

  
Source:
Document ID
2044-5644
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Ghana Pharmaceuticals and Healthcare Report" Aug 27, 2016. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Ghana-Pharmaceuticals-and-Healthcare-Report-2026-2421>
  
APA:
Business Monitor International - Industry Reports. (2016). Ghana Pharmaceuticals and Healthcare Report Aug 27, 2016. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Ghana-Pharmaceuticals-and-Healthcare-Report-2026-2421>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.